Pittsburgh

CDC panel backs expanded COVID-19 vaccine booster rollout – Pittsburgh, Pennsylvania

Pittsburgh, Pennsylvania 2021-10-21 17:46:00 –

Millions of Americans are approaching getting a COVID-19 booster as influential government advisers approved additional doses of all three of the country’s vaccines on Thursday-and people are next. He said he could choose another company’s brand for the shot. Previously already qualified as a booster, the Centers for Disease Control and Prevention adviser now states that certain Modana and Johnson & Johnson recipients also need to be qualified. And with a bigger change, the panel opened the option of “mixing and matching” to allow additional doses of vaccines different from the type people originally received. The Food and Drug Administration had already approved such an expansion of the country’s booster campaign on Wednesday, but the CDC, led by its advisory board, was the last on who should roll up their sleeves. I have a word. CDC Director Dr. Rochelle Walensky will soon rule. This is the latest news. The previous story continues below. Influential government advisers decided on Thursday the best way to expand the country’s COVID-19 booster campaign, including whether and when it’s okay to “mix” the brand for additional doses. increase. The bigger question is who should receive additional doses of Moderna or Johnson & Johnson vaccines, and getting boosters a brand different from the people’s original vaccine. The Food and Drug Administration approved both steps on Wednesday as part of a federal promotion to expand boosters for US citizens’ access. However, the CDC is guided by its advisory board and provides the final blessing. Approximately two-thirds of Americans on COVID-19 shots are fully vaccinated, and millions have received additional Pfizer vaccines after the FDA and CDC granted their permission. increase. Last month ahead. Health officials want boosters to boost immunity to mild coronavirus infections, but all vaccines still provide strong protection against hospitalization and death, and the first unvaccinated injection. Give priority to. “For most individuals, in most situations, COVID deaths-19 can be prevented with a vaccine,” he said. CDC adviser Dr. Matthew Daily of Kaiser Permanente Corona promises a tough decision at Thursday’s meeting, similar to the panel facing Pfizer’s boosters. Ultimately, these boosters were recommended for everyone over the age of 65, nursing home residents, and young adults who are at high risk of infection due to health problems, work, or living conditions. This includes health care workers, teachers, people in prisons and homeless shelters. The FDA cleared half of Moderna’s boosters in the same group six months after the last shot. However, for J & J’s one-shot vaccine, the FDA said all US recipients only have to wait two months after the first vaccination. The agency said adults who took J & J shots should be eligible for boosters. This is a study-based decision showing that a single dose of J & J is significantly less effective than a single dose of Pfizer or Moderna. When it comes to mixed-and-match questions, the FDA has opened up a way for anyone who qualifies as a booster to get one of the country’s three certified brands at that additional dose. The FDA has emphasized the utility of having access to boosters offered by certain pharmacies and clinics. Especially against COVID-19, the majority of approximately 190 million Americans who are fully vaccinated in long-term care facilities and other facilities where residents receive various shots over time. Received Pfizer or Moderna options, but J & J has only about 15 million recipients. The Associated Press Health & Science Department is supported by the Science Education Department of the Howard Hughes Medical Institute. AP is solely responsible for all content.

Millions of Americans are approaching getting a COVID-19 booster as influential government advisers approved additional doses of all three vaccines in the country on Thursday-and people are getting their hands on it. He said he could choose another company’s brand for the next shot.

Certain people who were vaccinated with Pfizer a few months ago were already qualified as boosters, and now Centers for Disease Control and Prevention advisors say that certain Modana and Johnson & Johnson recipients also need to qualify. say. And with a bigger change, the panel opened up a “mixing and matching” option that allows for additional doses of vaccine that are different from the type people originally received.

The Food and Drug Administration has already approved such an expansion of the country’s booster campaign on Wednesday, but the CDC led by its advisory board has the final word on who should roll up their sleeves. increase. CDC Director Dr. Rochelle Walensky will soon rule.

This is the latest news update. The previous story continues below.

Influential government advisers have decided on Thursday the best way to expand the country’s COVID-19 booster campaign.

Centers for Disease Control and Prevention advisors will discuss who should receive additional doses of Moderna or Johnson & Johnson vaccines, and the larger issue of getting boosters a brand different from the people’s original vaccinations.

The Food and Drug Administration approved both steps on Wednesday. This is part of the federal government’s push to increase booster access for US citizens. However, the CDC is guided by its advisory board and provides the final blessing.

Approximately two-thirds of Americans on COVID-19 shots are fully vaccinated, and millions have received additional Pfizer vaccines after the FDA and CDC granted their approval last month. I am. Health officials want boosters to boost immunity to mild coronavirus infections, but all vaccines still provide strong protection against hospitalization and death, and the first unvaccinated injection. Give priority to.

“For most people, in most situations, COVID-19 death can be prevented with a vaccine,” said CDC Advisor Dr. Matthew Daily of Kaiser Permanente Colorado.

Thursday’s meeting promises tough decisions, like the panel facing Pfizer’s boosters. Ultimately, these boosters were recommended for everyone over the age of 65, nursing home residents, and young adults who are at high risk of infection due to health problems, work, or living conditions. This includes health care workers, teachers, people in prisons and homeless shelters.

The FDA cleared half of Moderna’s boosters in the same group six months after the last shot.

However, for J & J’s one-shot vaccine, the FDA said all US recipients only have to wait two months after the first vaccination. The agency said adults who took J & J shots should be eligible for boosters. This is a study-based decision showing that a single dose of J & J is significantly less effective than a single dose of Pfizer or Moderna.

When it comes to mixed-and-match questions, the FDA has opened up a way for anyone who qualifies as a booster to get one of the country’s three certified brands at that additional dose. The FDA has emphasized the utility of having access to boosters offered by certain pharmacies and clinics. Especially for use in nursing homes and other facilities where residents receive various shots over time.

The majority of the approximately 190 million Americans who have been fully vaccinated with COVID-19 receive the Pfizer or Moderna option, but only approximately 15 million J & J recipients.

___

The Associated Press’s Department of Health Sciences is supported by the Department of Science Education at the Howard Hughes Medical Institute. AP is solely responsible for all content.

CDC panel backs expanded COVID-19 vaccine booster rollout Source link CDC panel backs expanded COVID-19 vaccine booster rollout

Back to top button